Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rayelle Itoua Maïga

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Immunology Research|March 12, 2015
Human CD38hiCD138⁺ plasma cells can be generated in vitro from CD40-activated switched-memory B lymphocytesRayelle Itoua Maïga, Guillaume Bonnaure, Josiane Tremblay Rochette, et al.
Cellular and Molecular Life Sciences : CMLS|December 23, 2016
Developing anti-neoplastic biotherapeutics against eIF4FJutta Steinberger, Jennifer Chu, Rayelle Itoua Maïga, et al.
Biomed Research International|April 2, 2014
Flow cytometry assessment of in vitro generated CD138+ human plasma cellsRayelle Itoua Maïga, Jennifer Lemieux, Annie Roy, et al.
Methods in Enzymology|November 16, 2014
Adapting CRISPR/Cas9 for functional genomics screensAbba Malina, Alexandra Katigbak, Regina Cencic, et al.
RNA (New York, N.Y.)|February 5, 2020
A comparative study of small molecules targeting eIF4ASai Kiran Naineni, Rayelle Itoua Maïga, Regina Cencic, et al.
Scientific Reports|February 6, 2019
Oxo-aglaiastatin-Mediated Inhibition of Translation InitiationRayelle Itoua Maïga, Regina Cencic, Jennifer Chu, et al.
Nucleic Acids Research|August 9, 2020
Identification and characterization of hippuristanol-resistant mutants reveals eIF4A1 dependencies within mRNA 5' leader regionsJutta Steinberger, Leo Shen, Stephen J Kiniry, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Immunology Research|March 12, 2015
Human CD38hiCD138⁺ plasma cells can be generated in vitro from CD40-activated switched-memory B lymphocytesRayelle Itoua Maïga, Guillaume Bonnaure, Josiane Tremblay Rochette, et al.
Cellular and Molecular Life Sciences : CMLS|December 23, 2016
Developing anti-neoplastic biotherapeutics against eIF4FJutta Steinberger, Jennifer Chu, Rayelle Itoua Maïga, et al.
Biomed Research International|April 2, 2014
Flow cytometry assessment of in vitro generated CD138+ human plasma cellsRayelle Itoua Maïga, Jennifer Lemieux, Annie Roy, et al.
Methods in Enzymology|November 16, 2014
Adapting CRISPR/Cas9 for functional genomics screensAbba Malina, Alexandra Katigbak, Regina Cencic, et al.
RNA (New York, N.Y.)|February 5, 2020
A comparative study of small molecules targeting eIF4ASai Kiran Naineni, Rayelle Itoua Maïga, Regina Cencic, et al.
Scientific Reports|February 6, 2019
Oxo-aglaiastatin-Mediated Inhibition of Translation InitiationRayelle Itoua Maïga, Regina Cencic, Jennifer Chu, et al.
Nucleic Acids Research|August 9, 2020
Identification and characterization of hippuristanol-resistant mutants reveals eIF4A1 dependencies within mRNA 5' leader regionsJutta Steinberger, Leo Shen, Stephen J Kiniry, et al.
Pageof 1